BRIEF published on 09/13/2024 at 08:05, 1 year 10 months ago Clariane joins the SBF 120 index SBF 120 Financial Growth Clariane Paris Stock Exchange Mission-driven Company
PRESS RELEASE published on 09/13/2024 at 08:00, 1 year 10 months ago Informations privilégiées / Autres communiqués Clariane intègre l’indice SBF 120, rejoignant les 120 premières valeurs cotées sur Euronext Paris en termes de liquidité et capitalisation boursière Euronext Paris Clariane Indice SBF 120 Valeurs Cotées Fragilité
BRIEF published on 08/05/2024 at 18:54, 2 years ago Sophie Boissard renewed as Managing Director of the Clariane Group Renewal Leadership Management Health Clariane
BRIEF published on 08/05/2024 at 18:54, 2 years ago Sophie Boissard renouvelée comme Directrice générale du Groupe Clariane Renouvellement Leadership Santé Gestion Clariane
PRESS RELEASE published on 08/05/2024 at 18:49, 2 years ago Inside Information / Other news releases Sophie Boissard reappointed as CEO of Clariane Group for a 5-year term. Board of Directors shows full confidence in her leadership. Clariane Group aims for balanced development and value creation CEO Renewal Value Creation Sophie Boissard Clariane Group
PRESS RELEASE published on 08/05/2024 at 18:49, 2 years ago Informations privilégiées / Autres communiqués Renouvellement de Sophie Boissard comme Directrice Générale du Groupe Clariane, société à mission. Confiance renouvelée du Conseil d'Administration. Clariane, communauté européenne de soin Société À Mission Renouvellement Sophie Boissard Groupe Clariane Soin Fragilité
BRIEF published on 06/26/2024 at 18:45, 2 years 1 month ago Clariane finalise la cession de « Les Essentielles » à Odalys Clariane Élimination Odalys Les Essentielles Groupe Duval
BRIEF published on 06/26/2024 at 18:45, 2 years 1 month ago Clariane Finalizes Disposal of "Les Essentielles" to Odalys Disposal Clariane Odalys Les Essentielles Duval Group
PRESS RELEASE published on 06/26/2024 at 18:40, 2 years 1 month ago Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...) Clariane confirme la cession de son activité de résidences services en France 'Les Essentielles' au Groupe Duval via sa filiale Odalys. La transaction porte sur 18 résidences Cession France Clariane Odalys Résidences Services
PRESS RELEASE published on 06/26/2024 at 18:40, 2 years 1 month ago Inside Information / Operations of the issuer (acquisitions, sales...) Clariane confirms the disposal of its activity "Les Essentielles" to Odalys, a subsidiary of the Duval Group, involving 18 residences and part of its strategic investment reallocation plan Investment Disposal Clariane Odalys Les Essentielles
Published on 08/10/2026 at 08:00, 2 hours 39 minutes ago Galantas Gold Expands Indiana Drill Program to 12,500 Metres
Published on 08/10/2026 at 08:00, 2 hours 39 minutes ago Results of AGM and Management Update Presentation
Published on 08/07/2026 at 23:15, 2 days 11 hours ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 2 days 11 hours ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/10/2026 at 10:12, 26 minutes ago Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 08/10/2026 at 10:10, 28 minutes ago Hana Bank Subsidiary GLN Expands QR Payment Network for International Travelers to Korea
Published on 08/10/2026 at 09:50, 49 minutes ago Photon Energy N.V. Bond 21/27 (ISIN: DE000A3KWKY4): Signs of a crisis are mounting. What can investors do? Invitation to video conferences (German/English)
Published on 08/10/2026 at 09:00, 1 hour 38 minutes ago Original-Research: Rosenbauer International AG (von NuWays AG): BUY
Published on 08/10/2026 at 09:00, 1 hour 38 minutes ago Original-Research: Bittium Oyj (von NuWays AG): BUY
Published on 08/10/2026 at 09:22, 1 hour 16 minutes ago Number of shares and voting rights - July 2026 (In French only)
Published on 08/10/2026 at 09:22, 1 hour 16 minutes ago Nombre total d'actions et droits de vote - juillet 2026
Published on 08/10/2026 at 07:00, 3 hours 39 minutes ago BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
Published on 08/10/2026 at 07:00, 3 hours 39 minutes ago Biophytis annonce l’autorisation de l’étude clinique OBA au Brésil et partage les perspectives de BIO101 dans l’obésité
